NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/30/2023
Back to search
Official data from USPTO
MAGNAFOLATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
10/30/2023
Trademark type
Combined
Nice classes
5
Filing date
02/19/2017
Registration date
09/12/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/30/2023
Last transaction
10/30/2023
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
10/01/2016
First use in commerce
10/01/2016
Drawing code
5
Owner type
99
Owner location
Jiangsu, CN
Examiner
BUONGIORNO, CHRISTOPHER
Law office
L20
Current location
TMEG LAW OFFICE 102
Mark description
The mark consists of the stylized English wording "MAGNAFOLATE" written in a stylized form.
Holders and representatives
Holders
Lianyungang Jinkang Pharmaceutical Technology Co., Ltd.
Representatives
Neal Massand Ni, Wang & Massand, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical contraceptives; Dietary supplements for animals; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Dietetic foods adapted for medical use; Food for babies; Infant formula; Medicinal drinks; Medicines for alleviating constipation; Nutritional supplements; Pharmaceutical preparationsantivirals; Powdered milk for babies; Vitamin preparations; Anti-epileptic pharmaceutical preparations; Food supplementsanti-oxidants; Molecular complex for the delivery of non-radical oxygen for medicinalsurgicaltherapeutic or veterinary purposes; Pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Transdermal patches featuring smoking cessation preparationscaffeine for use as a stimulantvitamins for increasing energy; Veterinary preparationsantioxidants
Publications
History of USPTO decisions and trademark events.
13 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/30/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/30/2023
ES8R
TEAS SECTION 8 RECEIVED
06/27/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2017
PUBO
PUBLISHED FOR OPPOSITION
06/27/2017
NPUB
NOTICE OF PUBLICATION
06/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2017
DOCK
ASSIGNED TO EXAMINER
05/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2017
NWAP
NEW APPLICATION ENTERED
02/22/2017
Continuous trademark protection
Get notified about every new filing that threatens MAGNAFOLATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.